---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-014340"
form_type: "8-K"
ticker: null
cik: "0001138978"
company_name: "Novo Integrated Sciences, Inc."
filed_at: "2024-04-11T23:59:59+00:00"
generated_at: "2026-06-03T23:49:36.367249+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Novo Integrated Sciences closes $6.21M convertible note, repays prior debt

## Summary
- Entered $6.21M secured convertible note with Streeterville Capital; net proceeds $5.5M after OID and fees.
- Note bears 10.9% interest, matures April 8, 2025, convertible at 85% of lowest VWAP over prior 5 trading days.
- Proceeds used to repay in full Mast Hill $3.5M note and FirstFire $277,777 note, both dated September 2023.
- Monthly redemption right up to $950,000 starting Oct 2024, payable in cash or stock if equity conditions met.
- Company granted security interest in all assets; subsidiaries Acenzia and Novo Healthnet guaranteed the note.

## SEC filing metadata
- accession: 0001493152-24-014340
- form_type: 8-K
- cik: 0001138978
- company_name: Novo Integrated Sciences, Inc.
- filed_at: 2024-04-11T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1138978/000149315224014340/0001493152-24-014340-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1138978/000149315224014340/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-014340
- JSON: https://secwatch.observer/filing/0001493152-24-014340.json
- Plain text: https://secwatch.observer/filing/0001493152-24-014340.txt

## Key facts
- Debt Financings
  Novo Integrated Sciences, Inc. incurred convertible notes of $6,210,000 with Streeterville Capital, LLC at 10.9% per annum maturing April 8, 2025.
  - Instrument: convertible notes
  - Principal: $6,210,000
  - Counterparty: Streeterville Capital, LLC
  - Rate: 10.9% per annum
  - Maturity: April 8, 2025
  - Event: incurrence
  source text: On April 5, 2024, Novo Integrated Sciences, Inc. (the “Company”) entered into a securities purchase agreement (the “SPA”) with Streeterville Capital, LLC (the “Holder”), pursuant to which the Company issued a secured convertible promissory note (the “Note”) with a maturity date of April 8, 2025 (the “Maturity Date”), in the principal sum of $6,210,000 (the “Principal Sum”). Pursuant to the terms of the Note, the Company agreed to pay the Principal Sum to the Holder and to pay interest on the principal balance at the rate of 10.9% per annum.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1138978/000149315224014340/0001493152-24-014340-index.htm
- Material Agreements
  Novo Integrated Sciences, Inc. entered into Securities Purchase Agreement with Streeterville Capital, LLC valued at $6,210,000 (effective 2024-04-05).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: Streeterville Capital, LLC
  - Value: $6,210,000
  - Effective: 2024-04-05
  source text: On April 5, 2024, Novo Integrated Sciences, Inc. (the “Company”) entered into a securities purchase agreement (the “SPA”) with Streeterville Capital, LLC (the “Holder”), pursuant to which the Company issued a secured convertible promissory note (the “Note”) with a maturity date of April 8, 2025 (the “Maturity Date”), in the principal sum of $6,210,000 (the “Principal Sum”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1138978/000149315224014340/0001493152-24-014340-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.